News

Greg Cogan, PhD, comments on a recent mice study tying to the evolution of speech.

Andrew West, PhD, is featured in this article discussing a study of microplastics in the human body.

This story comes from the Fall 2024 edition of Coming Down The Pipeline: What's new & next at the DCRI, and the people making it happen sent out on December 11, 2024. Learn more about the DCRI on their website.

More than half of patients who develop Parkinson’s Disease (PD) have a history of complaints related to the gastrointestinal (GI) system, such as chronic nausea or constipation.

The Office of Research and Innovation has named seed grant recipients for two programs, the Duke Science & Technology SPARK fund and the Duke Science & Technology LAUNCH fund.

Carlene Moore, PhD and Laurie Sanders, PhD, have been named Scialog: Neurobiology and Changing Ecosystems Fellows.

Read about Ornit Chiba-Falek, PhD's collaboration to develop a new platform that targets specific genes that can cause disease.

In January, members of Duke Neurology wrote and contributed to 20 peer-reviewed journal articles. This month’s research includes an article reviewing interneuron transplantation for drug-resistant epilepsy, a study on the relationship between BMI and intracerebral hemorrhage, and a study indicating that genetic associations with longevity are stronger in females than in males. 

Silas Buck, PhD, first fell in love with neuroscience during the earliest days of his undergraduate career, when he became fascinated with the complex biological reactions that were responsible for even his earliest lab experiments. Buck pursued this passion through graduate school, studying how dopamine neurons become vulnerable to degeneration in Parkinson’s disease.